A number of blood biomarkers were reported to be useful in predicting diagnosis or prognosis in ILD, including surfactant proteins A (SP-A) and D (SP-D), monocyte chemoattractant proteins 1 (MCP-1) and 7 (MCP-7), chemokine ligand 18 (CCL-18), interleukin-8 (IL-8), and Krebs von den Lungen-6 (KL-6) [14–18]. Here, CXCL8 is linked to interstitial lung disease.